Cell-based Non-invasive Prenatal Test Workflow

NCT07566780 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2026-05-05

No results posted yet for this study

Summary

The aim of this study is to optimize a new non-invasive prenatal screening method based on the capture of fetal cells from maternal blood and to complete its development by obtaining maternal blood samples during the first trimester of pregnancy.

Conditions

  • Pregnant Women

Interventions

OTHER

Blood collection

Samples of peripheral blood (30 ml) will be collected from pregnant women

Sponsors & Collaborators

  • Menarini Silicon Biosystems

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-04
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07566780 on ClinicalTrials.gov